doi:https://doi.org/

References:

Lloyd-Jones D., Adams R.J., Brown T.M., et al. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 2010; 121: e46—215.
Wolf-Maier K., Cooper R.S., Kramer H., et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10—17.
Esler M., Jennings G., Korner P., et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988;11:3—20.
DiBona G.F., Kopp U.C. Neural control of renal function. Physiol Rev 1997;77:75—197.
Kopp U.C., Cicha M.Z., Smith L.A., et al. Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of alpha1- and alpha2-adrenoceptors on renal sensory nerve fibers. Am J Physiol Regul Integr Comp Physiol 2007;293:R1561—1572.
Hausberg M., Kosch M., Harmelink P., et al. Sympathetic nerve activity in end-stage renal disease. Circulation 2002;106:1974—1979.
Stella A., Zanchetti A. Functional role of renal afferents. Physiol Rev 1991;71:659—682.
Hoobler S.W., Manning J.T., Paine W.G., et al. The effects of splanchnicectomy on the blood pressure in hypertension; a controlled study. Circulation 1951;4:173—183.
Smithwick R.H., Thompson J.E. Splanchnicectomy for essential hypertension; results in 1,266 cases. J Am Med Assoc 1953;152:1501—1504.
Schlaich M.P., Sobotka P.A., Krum H., et al. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009;361:932—934.
Krum H., Schlaich M., Whitbourn R., et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicenter safety and proof-of-principle cohort study. Lancet 2009;373:1275—1281.
Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206—1252.
Mancia G., De Backer G., Dominiczak A., et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462—1536.
Calhoun D.A., Jones D., Textor S., et al. Resistant hypertension: diagnosis, evaluation and treatment. Circulation 2008;117:e510—526.
Sarafidis P.A., Bakris G.L. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 2008;52:1749—1757.
Williams B. Resistant hypertension: an unmet treatment need. Lancet 2009;374:1396—1398.
Weber M.A., Black H., Bakris G., et al. A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomized, double-blind, placebo-controlled trial. Lancet 2009;374:1423—1431.
Bakris G.L., Lindholm L.H., Black H.R., et al. Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial. Hypertension 2010;56:824—830.
Scheffers I.J., Kroon A.A., Schmidli J., et al. Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol 2010;56:1254—1258.
Doumas M., Douma S. Renal sympathetic denervation: the jury is still out. Lancet 2010;376:1878—1880.
Doumas M., Faselis C., Papademetriou V. Renal sympathetic denervation and systemic hypertension. Am J Cardiol 2010;105:570—576.
Peet M.M. Hypertension and its surgical treatment by bilateral supradiaphragmatic splanchnicectomy. Am J Surg 1948;75:48—68.